Kushco Holdings Inc (KSHB) |
|
Price: $0.0000
$0.00
%
|
Day's High:
| 0.00
| Week Perf:
|
|
Day's Low: |
$ 0.00 |
30 Day Perf: |
|
Volume (M): |
0 |
52 Wk High: |
$ 0.00 |
Volume (M$): |
$ 0 |
52 Wk Avg: |
$0.00 |
Open: |
$0.00 |
52 Wk Low: |
$0.00 |
|
|
Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
159 |
Employees |
29 |
Revenues (TTM) (Millions $) |
114 |
Net Income (TTM) (Millions $) |
-25 |
Cash Flow (TTM) (Millions $) |
-10 |
Capital Exp. (TTM) (Millions $) |
2 |
Kushco Holdings Inc
Kush Bottles, Inc. was incorporated in the state of Nevada on February 26,
2014. The Company specializes in the wholesale distribution of packaging supplies
for the cannabis industry. The Company’s wholly owned subsidiary Kim International
Corporation (KIM), a California corporation, was originally incorporated as
Hy Gro Economics Corporation ("Hy Gro") on December 2, 2010. On October
30, 2012, Hy Gro amended its articles of incorporation to reflect a name change
to KIM International Corporation (KIM).
Kush Bottles, Inc. markets and sells packaging products and solutions to customers
operating in the regulated medical and recreational cannabis industries. As
an innovator in custom packaging design and implementation, we combine creativity
with compliance to provide the right solutions for our customers. The ability
to source almost anything a customer needs makes us a one-stop-shop packaging
solutions provider. We also provide custom branding on packaging products. This
feature allows our customers to turn their packaging into marketing or re-marketing
campaigns. Our core products are in accordance with Title 16 of the Code of
Federal Regulations Part 1700 of the Poison Prevention Packaging Act. The testing
standards for certification meet the stringent requirements as set by the Consumer
Product Safety Commission (“CPSC”) and ASTM International (“ASTM”).
In addition, the materials used for production are FDA-approved food grade and
BPA-free. By offering a product mix that is already tested compliant, we give
peace of mind to customers and reduce liability on their end. By working with
a broad array of manufacturers, we can offer quick solutions to our customers
and ensure that their products will be of superior grade and made with environmentally
safe materials.
Our packaging business primarily consists of bottles, bags, tubes, and containers.
We maintain relationships with a broad range of manufacturers, which enables
us to source a plethora of packaging products in a cost effective manner and
pass such cost savings to our customers. In addition to a complete product line,
we have sophisticated labeling and customization capabilities, which allow us
to add significant value to our customers’ packaging design processes.
Our products are utilized by local urban farmers, green house growers, and medical
and recreational cannabis dispensaries.
Bottles. Our flagship product is the certified child-resistant Phillips RX
pop-top vial. Our pop top bottles meet all of the standards for both CPSC and
ASTM. The pop-top bottle is unique to the pharmaceutical packaging world because
instead of a traditional push and turn bottle, the pop-top requires a squeeze
motion that actually pops the attached top up and open. We carry the bottles
in various sizes and colors. We believe, based on management estimates, that
we are a leading packaging supplier in the cannabis market.
Bags. We provide an array of packaging solutions in the form of a bag. The
selection of bags we provide includes child resistant exit bags, traditional
paper exit bags, and a vast selection of food grade safe foil barrier bags.
All bags are available in stock designs and are fully customizable.
Tubes. We offer a complete line of tubes in two standard sizes, each available
in a wide variety of colors. We believe that we are one of the largest suppliers
of tubes to the cannabis industry in the United States. Our focus and investments
are made to ensure that we are able to meet the increasing trend towards impermeable
casing, substantially extending shelf life for pre-packaging. The tubes have
a positive seal for enhanced freshness and are odor tight for secure storage
and content privacy. All tubes are medical grade plastic, BPA-free, and molded
of natural gas based polypropylene in compliance with FDA regulation. We maintain
several unique designs in this market that combine tube and closure that we
believe are viewed as very innovative both in appearance and functionality.
We believe that our ability to provide creative package designs, combined with
a complementary line of closures, makes us a preferred supplier for many customers
in our target market.
Containers. We provide a diverse selection of smaller sized containers composed
of either polystyrene, polypropylene or silicone. Our screw-top silicone containers
come in assorted customizable colors and are composed of non-stick material
whereas our BPA-free medical grade polypropylene hinged-top containers maintain
an odorless seal.
We have an active public relations program, which has helped build the Kush
brand and position the Company not only as a leader in the industry, but as
the company with expertise in compliance issues and depth of understanding into
state and local regulations governing the cannabis industry. This expertise
is provided to our business-to-business customers, to help them stay compliant
and operate within all applicable rules.
Company Address: 6261 Katella Avenue Cypress 90630 CA
Company Phone Number: 462-4603 Stock Exchange / Ticker: KSHB
|
|
|
|
|
Stock Performances by Major Competitors |
|
|
Exagen Inc
Exagen Inc (Nasdaq: XGN) has shown significant signs of weakness in its latest financial report for the fourth quarter of 2023. Despite a decrease in the loss per share compared to the previous year, the company still reported a loss of $-0.30 per share. This is only a slight improvement from the loss of $-0.83 per share in the same period a year prior. Although there was a 7.229% increase in revenue to $13.77 million from $12.84 million in the corresponding reporting season, this is a relatively small growth rate and not enough to inspire confidence in the company's prospects. The sequential revenue growth of 2.601% from $13.42 million is also modest at best.
|
Enzo Biochem Inc
Enzo Biochem Inc, a medical laboratories company, experienced a stable stock performance in March 2024 with no change in its share price. However, this brings the share price to a decrease of 11.33% in the first quarter of 2024. Additionally, the stock is currently trading only 33% above its 52-week low. For the financial second quarter of 2024, Enzo Biochem Inc reported a significant improvement in its earnings per share (EPS) compared to the previous year. The loss per share decreased from $-0.23 to $-0.06. Furthermore, the EPS also improved from the preceding quarter, going from $-0.13 to $-0.06.
|
Ispecimen Inc
iSpecimen Inc. (Nasdaq: ISPC) is a pioneering online marketplace that connects scientists with healthcare specimen providers for research purposes. The company, headquartered in Lexington, Massachusetts, has recently announced that it will unveil its full-year financial results for the period ending December 31, 2023, on March 13, 2024. Stakeholders are eagerly awaiting the release of these results, as iSpecimen is globally recognized for its innovative platform that facilitates breakthrough discoveries and accelerates scientific advancements. The previous fiscal span, from October to December 31, 2023, saw iSpecimen Inc. experience a deficit per share of $-0.33, compared to $-0.20 the previous year. This represents a growth in deficit per share from $-0.23 from the prior reporting season. Additionally, the company's revenue declined by -13.049% to $2.58 million from $2.96 million in the comparable reporting season a year before. Sequentially, revenue deteriorated by -7.296% from $2.78 million.
|
Maxcyte Inc
Maxcyte Inc, a leading cell-engineering focused company, recently announced its fourth quarter and full year financial results for 2023. The company reported a surge in revenue by 26.087% to $15.66 million from the same reporting period a year before. However, it also experienced diminishing returns with a net shortfall of $-0.05 per share. Despite the positive revenue growth, Maxcyte Inc's shares have gone down by -15.63% in the past 5 trading days and -14.35% from a year ago. Currently, the company's shares are trading on the NASDAQ by -8.4% below its 52 week average.
|
Butterfly Network Inc
Butterfly Network Inc Reports Decreased Loss Per Share, Declining Revenue for Q4 2023 BURLINGTON, Mass. and NEW YORK - Butterfly Network, Inc. (NYSE: BFLY), a digital health company focused on portable, semiconductor-based ultrasound technology, announced its financial results for the quarter and year ended December 31, 2023. The company also provided an update on its business activities. Butterfly Network aims to make medical imaging more accessible through its innovative product offerings, software solutions, and educational programs. For the financial period closing December 31, 2023, Butterfly Network reported a loss of $-0.21 per share, showing an improvement from the loss of $-0.31 per share in the previous year. However, there was an increased loss compared to the previous reporting period, from $-0.13 per share. The company's revenue declined by 14.346% to $17.08 million from $19.94 million, in the comparable reporting period a year prior. Nevertheless, sequentially, the revenue advanced by 11.013%, from $15.38 million.
|
Per Share |
Current |
Earnings (TTM) |
-0.18 $ |
Revenues (TTM) |
0.72 $
|
Cash Flow (TTM) |
- |
Cash |
0.01 $
|
Book Value |
0.75 $
|
Dividend (TTM) |
0 $ |
|
Per Share |
|
Earnings (TTM) |
-0.18 $
|
Revenues (TTM) |
0.72 $ |
Cash Flow (TTM) |
- |
Cash |
0.01 $
|
Book Value |
0.75 $ |
Dividend (TTM) |
0 $ |
|
|
|
|